Zeyan Y. Shi

Nanning, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Seven-day Venetoclax Combined With Dose-adjusted Intensive Chemotherapy as Induction Treatment in Newly Diagnosed Acute Myeloid Leukemia.

Seven-day Venetoclax Combined With Dose-adjusted Intensive Chemotherapy as Induction Treatment in Newly Diagnosed Acute Myeloid Leukemia.

Journal: Clinical lymphoma, myeloma & leukemia

Published: March 06, 2026

Transforming the treatment of Alpha-Thalassemia: a single-center retrospective study on hematopoietic stem cell transplantation in transfusion-dependent pediatric patients.

Transforming the treatment of Alpha-Thalassemia: a single-center retrospective study on hematopoietic stem cell transplantation in transfusion-dependent pediatric patients.

Journal: Annals of hematology

Published: May 28, 2025

Venetoclax combined with homoharringtonine, cytarabine and aclacinomycin as induction therapy in newly diagnosed Chinese acute myeloid leukaemia patients: A multicentre phase II study.

Venetoclax combined with homoharringtonine, cytarabine and aclacinomycin as induction therapy in newly diagnosed Chinese acute myeloid leukaemia patients: A multicentre phase II study.

Journal: British journal of haematology

Published: March 19, 2025

Using T-lymphocyte subsets at engraftment to predict the risk of acute graft-versus-host disease in patients with thalassemia major: development of a new predictive nomogram.

Using T-lymphocyte subsets at engraftment to predict the risk of acute graft-versus-host disease in patients with thalassemia major: development of a new predictive nomogram.

Journal: Therapeutic advances in hematology

Published: May 28, 2024

Cerebral toxoplasmosis after hematopoietic stem cell transplantation in two children with thalassemia

Cerebral toxoplasmosis after hematopoietic stem cell transplantation in two children with thalassemia

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: February 27, 2023

MiR-181a-2-3p as a potential diagnostic and prognostic marker for myelodysplastic syndrome.

MiR-181a-2-3p as a potential diagnostic and prognostic marker for myelodysplastic syndrome.

Journal: Hematology (Amsterdam, Netherlands)

Published: November 29, 2022

Characterization of bone marrow heterogeneity in NK-AML (M4/M5) based on single-cell RNA sequencing.

Characterization of bone marrow heterogeneity in NK-AML (M4/M5) based on single-cell RNA sequencing.

Journal: Experimental hematology & oncology

Published: October 20, 2022

Expression and clinical significance of RAG1 in myelodysplastic syndromes.

Expression and clinical significance of RAG1 in myelodysplastic syndromes.

Journal: Hematology (Amsterdam, Netherlands)

Published: September 27, 2022

An immune-related gene prognostic index for acute myeloid leukemia associated with regulatory T cells infiltration.

An immune-related gene prognostic index for acute myeloid leukemia associated with regulatory T cells infiltration.

Journal: Hematology (Amsterdam, Netherlands)

Published: September 14, 2022

An occult urothelial carcinoma with wide multiorgan metastases and its genetic alteration profiling: Case report and literature review.

An occult urothelial carcinoma with wide multiorgan metastases and its genetic alteration profiling: Case report and literature review.

Journal: Medicine

Published: April 23, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026